logo
Dana Incorporated Reports 2025 First-quarter Financial Results in Line with Expectations; Maintained Sales and Adjusted EBITDA Guidance Ranges

Dana Incorporated Reports 2025 First-quarter Financial Results in Line with Expectations; Maintained Sales and Adjusted EBITDA Guidance Ranges

First Quarter Highlights
MAUMEE, Ohio, April 30, 2025 /PRNewswire/ -- Dana Incorporated (NYSE: DAN) today announced financial results for the first quarter of 2025.
'Our efforts to transform the company into a stronger, more focused business are gaining momentum. The sale of our Off-Highway business is underway with a competitive process. We also continue to execute our cost-savings initiative and have taken further steps to accelerate the realization of our $300 million plan,' said R. Bruce McDonald, chairman and chief executive officer. 'While the situation remains fluid, we believe the impact of tariffs are manageable based on completed mitigation actions and expected substantial recoveries from customers.'
Sales for the first quarter of 2025 totaled $2.35 billion, compared with $2.74 billion in the same period of 2024.
Net income attributable to Dana was $25 million, or $0.17 per share, compared with $3 million, or $0.02 per share, in the first quarter of 2024. As a percentage of sales, the first quarter of 2025 was 1 percent compared to 0.1 percent last year.
During the first quarter of 2024, Dana entered into a definitive agreement to sell its non-core European Off-Highway hydraulics business. This business was classified as held for sale, and a $29 million loss was recognized to adjust the carrying value of net assets to fair value less estimated costs to sell. This sale agreement was terminated and the transaction did not close.
Adjusted net income attributable to Dana was $19 million, or $0.13 per share, for the first quarter of 2025, compared with adjusted net income of $37 million, or $0.26 per share, in 2024.
Adjusted EBITDA for the first quarter of 2025 was $188 million or 8 percent of sales, compared with $223 million or 8.2 percent of sales for the same period in 2024. The company's cost-savings program has mitigated the margin impact of lower volumes, tariffs, and cost inflation.
Operating cash flow in the first quarter of 2025 was a use of $37 million, compared with a use of $102 million in the same period of 2024. Adjusted free cash flow was a use of $101 million, compared with a use of $168 million in the first quarter of 2024.
'Our focus on managing working capital continues to show results as we have once again improved adjusted free cash flow in the first quarter. Our cost-savings actions and efficiency improvements are helping to offset the impact of tariffs until we can affect full recovery,' said Timothy Kraus, Dana senior vice president and chief financial officer. 'We are maintaining our guidance ranges for most of our measures including adjusted EBITDA and we expect that sales will increase slightly due to tariff recoveries and currency translation offsetting weaker end-market demand.'
Revised 2025 Financial Targets
Dana to Host Conference Call at 9 a.m. Wednesday, April 30
Dana will discuss its first-quarter results in a conference call at 9 a.m. EDT on Wednesday, April 30. The conference call can be accessed by telephone from both domestic and international locations using the information provided below:
Conference ID: 9943139
Participant Toll-Free Dial-In Number: 1 (888) 440-5873
Participant Toll Dial-In Number: 1 (646) 960-0319
Audio streaming and slides will be available online via a link provided on the Dana investor website: www.dana.com/investors. Phone registration will be available beginning at 8:30 a.m. EDT.
A webcast replay can be accessed via Dana's investor website following the call.
Non-GAAP Financial Information
Adjusted EBITDA is a non-GAAP financial measure which we have defined as net income (loss) before interest, income taxes, depreciation, amortization, equity grant expense, restructuring expense, non-service cost components of pension and other postretirement benefit costs and other adjustments not related to our core operations (gain/loss on debt extinguishment, pension settlements, divestitures, impairment, etc.). Adjusted EBITDA is a measure of our ability to maintain and continue to invest in our operations and provide shareholder returns. We use adjusted EBITDA in assessing the effectiveness of our business strategies, evaluating and pricing potential acquisitions and as a factor in making incentive compensation decisions. In addition to its use by management, we also believe adjusted EBITDA is a measure widely used by securities analysts, investors and others to evaluate financial performance of our company relative to other Tier 1 automotive suppliers. Adjusted EBITDA should not be considered a substitute for earnings (loss) before income taxes, net income (loss) or other results reported in accordance with GAAP. Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies.
Adjusted net income (loss) attributable to the parent company is a non-GAAP financial measure which we have defined as net income (loss) attributable to the parent company, excluding any discrete income tax items, restructuring charges, amortization expense and other adjustments not related to our core operations (as used in adjusted EBITDA), net of any associated income tax effects. This measure is considered useful for purposes of providing investors, analysts and other interested parties with an indicator of ongoing financial performance that provides enhanced comparability to net income attributable to the parent company reported by other companies. Adjusted net income (loss) attributable to the parent company is neither intended to represent nor be an alternative measure to net income (loss) attributable to the parent company reported in accordance with GAAP.
Diluted adjusted EPS is a non-GAAP financial measure which we have defined as adjusted net income (loss) attributable to the parent company divided by adjusted diluted shares. We define adjusted diluted shares as diluted shares as determined in accordance with GAAP based on adjusted net income (loss) attributable to the parent company. This measure is considered useful for purposes of providing investors, analysts and other interested parties with an indicator of ongoing financial performance that provides enhanced comparability to EPS reported by other companies. Diluted adjusted EPS is neither intended to represent nor be an alternative measure to diluted EPS reported in accordance with GAAP.
Adjusted free cash flow is a non-GAAP financial measure which we have defined as net cash provided by (used in) operating activities less purchases of property, plant and equipment plus proceeds from sale of property, plant and equipment. We believe adjusted free cash flow is useful to investors in evaluating the operational cash flow of the company inclusive of the spending required to maintain the operations. Adjusted free cash flow is not intended to represent nor be an alternative to the measure of net cash provided by (used in) operating activities reported in accordance with GAAP. Adjusted free cash flow may not be comparable to similarly titled measures reported by other companies.
The accompanying financial information provides reconciliations of adjusted EBITDA, diluted adjusted EPS and adjusted free cash flow to the most directly comparable financial measures calculated and presented in accordance with GAAP. We have not provided a reconciliation of our adjusted EBITDA and diluted adjusted EPS outlook to the most comparable GAAP measures of net income (loss) and diluted EPS. Providing net income (loss) and diluted EPS guidance is potentially misleading and not practical given the difficulty of projecting event driven transactional and other non-core operating items that are included in net income (loss) and diluted EPS, including restructuring actions, asset impairments and certain income tax adjustments. The accompanying reconciliations of these non-GAAP measures with the most comparable GAAP measures for the historical periods presented are indicative of the reconciliations that will be prepared upon completion of the periods covered by the non-GAAP guidance.
Forward-Looking Statements
Certain statements and projections contained in this news release are, by their nature, forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on our current expectations, estimates, and projections about our industry and business, management's beliefs, and certain assumptions made by us, all of which are subject to change. Forward-looking statements can often be identified by words such as 'anticipates,' 'expects,' 'intends,' 'plans,' 'predicts,' 'believes,' 'seeks,' 'estimates,' 'may,' 'will,' 'should,' 'would,' 'could,' 'potential,' 'continue,' 'ongoing,' and similar expressions, and variations or negatives of these words. These forward-looking statements are not guarantees of future results and are subject to risks, uncertainties, and assumptions that could cause our actual results to differ materially and adversely from those expressed in any forward-looking statement.
Dana's Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q, recent Current Reports on Form 8-K, and other Securities and Exchange Commission filings discuss important risk factors that could affect our business, results of operations and financial condition. The forward-looking statements in this news release speak only as of this date. Dana does not undertake any obligation to revise or update publicly any forward-looking statement for any reason.
About Dana Incorporated
Dana is a leader in the design and manufacture of highly efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company is shaping sustainable progress through its conventional and clean-energy solutions that support nearly every vehicle manufacturer with drive and motion systems; electrodynamic technologies, including software and controls; and thermal, sealing, and digital solutions.
Based in Maumee, Ohio, USA, the company reported sales of $10.3 billion in 2024 with 39,000 people in 30 countries across six continents. With a history dating to 1904, Dana was named among the 'World's Most Ethical Companies' for 2025 by Ethisphere and as one of 'America's Most Responsible Companies 2025" by Newsweek. The company is driven by a high-performance culture that focuses on valuing others, inspiring innovation, growing responsibly, and winning together, earning it global recognition as a top employer. Learn more at dana.com.
View original content to download multimedia: https://www.prnewswire.com/news-releases/dana-incorporated-reports-2025-first-quarter-financial-results-in-line-with-expectations-maintained-sales-and-adjusted-ebitda-guidance-ranges-302442254.html
SOURCE Dana Incorporated

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AIDCF Releases Landmark Report Highlighting Job Loss Crisis and Urges for Urgent Reforms in India's Cable TV Sector
AIDCF Releases Landmark Report Highlighting Job Loss Crisis and Urges for Urgent Reforms in India's Cable TV Sector

Business Upturn

time23 minutes ago

  • Business Upturn

AIDCF Releases Landmark Report Highlighting Job Loss Crisis and Urges for Urgent Reforms in India's Cable TV Sector

NEW DELHI , June 10, 2025 /PRNewswire/ — All India Digital Cable Federation today launched a landmark study titled ' State of Cable TV Distribution in India ' . Developed in collaboration with EY India, the report offers critical insights into the challenges, evolution, and future of India's cable television ecosystem. It brings together extensive field data and sectoral analysis to present a comprehensive view of the Cable TV distribution landscape. Based on inputs from over 28,000 Local Cable Operators (LCOs) across India , the report highlights a sharp decline in cable TV subscriptions—driven by rising channel costs and competition from unregulated platforms—which, in turn, has led to a significant employment crisis. Key findings of the report include: The workforce of surveyed LCOs declined by 31% since 2018 , with a reported loss of 37,835 jobs . When extrapolated nationally, the estimated job loss ranges between 1.14 lakh and 1.95 lakh . , with a reported loss of . When extrapolated nationally, the estimated job loss ranges between . Pay TV households declined by 40 million , from 151 million in 2018 to 111 million in 2024. , from 151 million in 2018 to 111 million in 2024. 93% LCOs reported a decline in their subscriber base since 2018; LCOs reported a since 2018; 49% of LCOs reported a drop in their monthly income . of LCOs reported a . 35% reported subscriber loss of over 40%. Key reforms suggested by the report include: Enabling of level-playing field across all content distribution mediums across all content distribution mediums Permitting differential pay TV pricing for different territories based on ability to pay for different territories based on ability to pay Activating over 20 million inactive STBs in India Restrict or limit the provision of live or slightly delayed transmission of pay TV content for free on other platforms Take a unified stand against piracy Mr. Sanjiv Shankar, Additional Secretary, Ministry of Consumer Affairs; Former Joint Secretary, Ministry of Information and Broadcasting, shared his remarks: 'This report is truly one of its kind—comprehensive, data-driven, and grounded in the realities of the ground-level cable ecosystem. It brings into focus the structural shifts and challenges within the sector, and provides a valuable evidence base for future policy-making.' Mr. S.N. Sharma, CEO of DEN Networks Limited and President of AIDCF, expressed his enthusiasm about the report: 'This report is perhaps the most comprehensive bottom-up view of the Pay TV distribution sector in recent times.' 'The report presents not just statistics but stories of lost livelihood impacting families and entrepreneurship, and they need be heard across the broadcasting ecosystem.' 'While the report presents conservative estimates, the situation is even more grave. When factoring in the closure of approximately 900 MSOs and 72,000 LCOs over the past six years, the total cumulative job loss is estimated to exceed 5.77 lakh.' 'We urge all stakeholders — including broadcasters, regulators, and our parent ministry — to use the report as a base to bring practical reforms and support the cable TV industry to thrive once again.' Mr. Ashish Pherwani, Partner, Media & Entertainment Sector, EY India, remarked that: 'This is a first-of-its-kind report that captures the true pulse of the cable TV distribution network in India . Its scale, depth of field data, and insight into last-mile realities make it a valuable resource for both industry and policymakers alike.' The report was released during a special event held at Shangri-La Eros, New Delhi , where senior policymakers, industry leaders, and key stakeholders from across the broadcasting and media landscape came together to deliberate on the findings and implications of this industry-first report. The report can be accessed from AIDCF's official website or by clicking on this link. About All India Digital Cable Federation (AIDCF) All India Digital Cable Federation is the apex body for Digital Multi-System Operators (MSOs) in India . AIDCF is the official voice for the Indian digital cable TV industry and works towards the overall growth of the sector. AIDCF has consistently championed the interests of the cable TV distribution industry and remains committed to promoting a fair, competitive, and sustainable broadcasting ecosystem. The members of the federation have a combined market share of > 65%. Members of AIDCF includes Asianet Satellite Communications Limited, DEN Networks Limited, Fastway Transmission Private Limited, GTPL Hathway Private Limited, Hathway Cable & Datacom Limited, Kerala Communicators Cable Limited, NXT Digital, SITI Cable Network Limited and UCN Cable Network Private Limited. Photo: View original content to download multimedia: Disclaimer: The above press release comes to you under an arrangement with PR Newswire. Business Upturn takes no editorial responsibility for the same.

Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025
Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025

Yahoo

time26 minutes ago

  • Yahoo

Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025

Caliway to deliver a corporate presentation on June 17 at the BIO International Convention 2025, the world's largest biotech industry event. For the first time at an international conference, Caliway will share preclinical results on CBL-514's potential new indication: combined with GLP-1 therapies to prevent post-treatment weight rebound. NEW TAIPEI CITY, June 10, 2025 /PRNewswire/ -- Caliway Biopharmaceuticals (TWSE: 6919) announced today its participation in the 2025 BIO International Convention, to be held from June 16 to 19 in Boston, U.S.A. Caliway's Vice President, April Yuan, will deliver an oral presentation on June 17, highlighting the company's latest progress in R&D and pipeline development. The presentation will cover recent updates on CBL-514, first-in-class injectable drug candidate for large-area, site-specific fat reduction, including its development across multiple indications—subcutaneous fat reduction, cellulite, and Dercum's disease. For the first time at an international conference, Caliway will also share preclinical data on a potential new indication: weight rebound management through a combination therapy with GLP-1 receptor agonists. As GLP-1 receptor agonists gain widespread use globally, post-discontinuation weight rebound has become a significant, yet unmet clinical concern. According to published studies, only 10% of patients are able to maintain weight loss after stopping GLP-1 treatment. Based on Caliway's preclinical data, co-administration of CBL-514 with GLP-1 significantly reduced post-discontinuation body weight regain and fat replenishment rate — suggesting that CBL-514 may help maintain weight loss outcomes after GLP-1 therapy. CBL-514 works by directly targeting the root cause—subcutaneous fat—through selective induction of adipocyte apoptosis. It may serve as a complementary combination therapy to GLP-1s, pairing systemic weight loss with precise body contouring. Caliway plans to submit a Phase 2 IND application to the U.S. FDA for this new indication in Q4 2025. "We believe post-weight-loss weight rebound is a promising unmet market need," said Vivian Ling, CEO of Caliway. "CBL-514 has the potential to serve as a complementary combination therapy with GLP-1 treatments — with GLP-1s driving weight reduction, and CBL-514 reshaping and maintaining outcomes through localized fat reduction, enhancing the overall treatment impact and long-term value." The BIO International Convention is the world's largest and most influential biotechnology event, attracting over 20,000 professionals and 5,000 companies from 80+ countries. It serves as a global platform for business development, innovation exchange, and investment. Caliway Presentation at BIO 2025: Date & Time: Tuesday, June 17, 2025 | 11:45 AM – 12:00 PM (EDT) Location: Room 154 | Boston Convention & Exhibition Center Speaker: April Yuan, VP, Caliway Biopharmaceuticals Session Info: About CBL-514CBL-514, a 505(b)(1) and first-in-class small-molecule drug developed by Caliway, is the world's first injectable lipolysis drug that induces adipocyte apoptosis to reduce subcutaneous fat in targeted areas without causing any systemic side effects on the central nervous system, cardiovascular system, and respiratory system. As of May 2025, 10 clinical trials with a total of 520 subjects have been completed with all efficacy and safety endpoints met. Caliway is currently investigating multiple indications for CBL-514, including non-surgical fat reduction, moderate-to-severe cellulite, and weight rebound management through a combination therapy with GLP-1-based treatments. CBL-514D, the same active pharmaceutical ingredients (APIs) but under different formulation, is being studied for additional indications such as Dercum's disease and more. About Caliway BiopharmaceuticalsCaliway Biopharmaceuticals (Caliway) is a clinical-stage biopharmaceutical company driven to breakthrough drug discovery of novel small-molecule therapeutics. Listed on the Taiwan Exchange (TWSE-6919), Caliway aims to become an innovative pharmaceutical leader in aesthetic medicine and other diseases. For more information, please visit: DisclaimerThis article and related information on this site contain forward-looking statements. The forward-looking information requires the Company to make numerous assumptions and is subject to inherent risks, uncertainties, and other factors that are beyond the control of the Company which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. The Company undertakes no obligation to timely inform, update, or revise the information on this site if circumstances should change. View original content to download multimedia: SOURCE Caliway Biopharmaceuticals Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Nordic Breakthrough for Unlimited Fossil-Free Energy - NOVATRON 1 Officially Inaugurated
Nordic Breakthrough for Unlimited Fossil-Free Energy - NOVATRON 1 Officially Inaugurated

Yahoo

time26 minutes ago

  • Yahoo

Nordic Breakthrough for Unlimited Fossil-Free Energy - NOVATRON 1 Officially Inaugurated

STOCKHOLM, June 10, 2025 /PRNewswire/ -- On June 9, NOVATRON 1 was officially inaugurated at the Royal Institute of Technology (KTH) in Stockholm - the EU's first private, fully integrated fusion plasma system. The event marks a historic milestone for Sweden and the Nordic region in the development of commercial fusion energy. With Novatron Fusion Group (NFG) leading the charge, the Nordics are uniquely positioned to shape the future of energy through innovation, collaboration, and technological leadership. Fusion technology has the potential to address some of the most pressing global challenges of our time - from climate change to growing energy demand. Realizing this potential requires cross-sector collaboration between industry, academia, and policymakers. NFG is actively working to establish a strong Nordic fusion cluster and position the region as a driving force in the transition to a sustainable energy future. The inauguration brought together representatives from across the Nordic innovation ecosystem - including industry, academia, and government - with nearly all parties from the Swedish Parliament's Energy Committee in attendance. The broad participation underscores the strong support for fusion's role in the future energy mix. - The inauguration of NOVATRON 1 is a milestone - not only for our company but for the entire Nordic region. We're showing that it's possible to take concrete steps toward commercial fusion energy here and now. Our vision is that the Nordics will realize fusion, and today's event is powerful proof that we're on the right path, says Peter Roos, CEO of Novatron Fusion Group. Fusion energy - often referred to as "The Holy Grail of Energy" - has the potential to deliver continuous, safe, and fossil-free baseload power. As one of Europe's leading fusion companies, NFG is not only advancing fusion energy in the Nordics but also helping to strengthen Europe's energy resilience. At a time when G7 nations are highlighting fusion as a strategic solution to the climate crisis and energy security, European independence and cooperation in the energy sector are more important than ever. - NFG's groundbreaking technology is a vital contribution from Sweden to Europe's energy independence and climate transition, says Professor Christer Fuglesang, KTH Space Center. The NOVATRON concept is based on a unique design by innovator Jan Jäderberg and has been developed by a world-class team of physicists, engineers, and researchers. The technology addresses one of the biggest challenges in commercial fusion: stable and continuous confinement of fusion plasma without interruptions in energy production. This is described in more detail in a scientific article published last week, which highlights, among other things, NOVATRON's potential to achieve groundbreaking energy exchange values. With this promising concept, NFG aims to provide cost-effective and globally scalable baseload power to the grid within the next decade. During the inauguration, visitors witnessed a live plasma experiment in the prototype facility - the Nordic region's first step toward a commercial fusion reactor and a fossil-free society. - We believe that NFG has a game changing formula and as an owner with a long-term mindset, we're excited to help accelerate the work towards limitless fossil-free energy, says Henrikki Talvitie, CEO of St1. For more information, please contact:Jeanette MattssonMarketing and Communications Director, Novatron Fusion GroupEmail: Phone: +46 76 051 75 16 This information was brought to you by Cision The following files are available for download: NFG press release Peter Roos, CEO of NFG Prof. Christer Fuglesang Swedish Parliament's Energy Committee and CEO of NFG View original content: Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store